Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

This study has been completed.
Sponsor:
Collaborator:
Watson Laboratories, Inc.
Information provided by:
Kremers Urban Development Company
ClinicalTrials.gov Identifier:
NCT01039233
First received: December 23, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)